Russian diplomat believes Western obsession with Assad leads to dead endRussian Politics & Diplomacy April 27, 10:30
Maria Sharapova wins first match after disqualificationSport April 27, 9:38
Abe expects progress in talks on peace treaty with RussiaWorld April 27, 9:06
Media: Israeli Air Force strike hits area near Damascus airportWorld April 27, 8:35
Russian diplomat believes US strikes on Syria make no military or political senseRussian Politics & Diplomacy April 27, 8:30
Diplomat believes Trump should be given chance to improve relations with RussiaRussian Politics & Diplomacy April 27, 8:10
Twelve militants of Islamic Jihad Mujahideen Jamaat grouping detained in KaliningradSociety & Culture April 27, 2:14
Russian Prosecutor General’s Office finds another 3 NGOs to be undesirableRussian Politics & Diplomacy April 26, 21:42
Moscow ‘seriously concerned’ about Turkish airstrikes in Iraq, SyriaRussian Politics & Diplomacy April 26, 20:55
TOKYO, May 22, 2013 /PRNewswire/ -- Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a subsidiary of Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo), announced on May 22 the actions that Ranbaxy has taken in recent years to address past conduct under prior management.
Daiichi Sankyo continues to support Ranbaxy in its efforts to address and correct the conduct of the past which led to the investigations by the U.S. Department of Justice ("DOJ") and the U.S. Food and Drug Administration ("USFDA"). These efforts include significant changes to Ranbaxy's management, culture, operations and compliance.
Daiichi Sankyo believes that certain former shareholders of Ranbaxy concealed and misrepresented critical information concerning the U.S. DOJ and FDA investigations. Daiichi Sankyo is currently pursuing its available legal remedies and cannot comment further on the subject at this time.
About Daiichi Sankyo Co., Ltd.
Listed: Code No.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges
President and CEO: Joji Nakayama
Noriaki Ishida, Corporate Officer & Vice President Corporate Communications Department Daiichi Sankyo Co., Ltd.